Literature DB >> 11485346

Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses.

S Sambhara1, A Kurichh, R Miranda, O James, B Underdown, M Klein, J Tartaglia, D Burt.   

Abstract

Profound alterations in humoral and cellular immune responses are a hallmark of aging, and understanding the immunobiology of aging is key to the success of preventive vaccination strategies. With aging, while recall or memory responses to influenza viral antigens for the most part remained unaltered, primary immune responses are severely impaired. The impaired primary responses are partly due to a lack of costimulation, as providing costimulation at the time of induction of primary immune responses against influenza virus vaccine partially reversed aged-related immune dysfunction and conferred enhanced protection. Inclusion of immunomodulators that up-regulate the expression of costimulatory molecules must be considered to improve the efficacy of vaccination in the elderly, particularly to novel immunogens. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485346     DOI: 10.1006/cimm.2001.1799

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

Review 1.  Immunity to influenza: the challenges of protecting an aging population.

Authors:  Jacqueline M Katz; Julie Plowden; Mary Renshaw-Hoelscher; Xiuhua Lu; Terrence M Tumpey; Suryaprakash Sambhara
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

3.  Impaired dendritic cell function in aging leads to defective antitumor immunity.

Authors:  Annabelle Grolleau-Julius; Erin K Harning; Lisa M Abernathy; Raymond L Yung
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 4.  CD8 T cell responses to influenza virus infection in aged mice.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Ageing Res Rev       Date:  2011-02-15       Impact factor: 10.895

5.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

6.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.

Authors:  Heather W Stout-Delgado; Xin Yang; Wendy E Walker; Bethany M Tesar; Daniel R Goldstein
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Immune response of macrophages from young and aged mice to the oral pathogenic bacterium Porphyromonas gingivalis.

Authors:  Yazdani B Shaik-Dasthagirisaheb; Alpdogan Kantarci; Frank C Gibson
Journal:  Immun Ageing       Date:  2010-11-29       Impact factor: 6.400

9.  Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Authors:  Rick A Bright; Donald M Carter; Corey J Crevar; Franklin R Toapanta; Jonathan D Steckbeck; Kelly S Cole; Niranjan M Kumar; Peter Pushko; Gale Smith; Terrence M Tumpey; Ted M Ross
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

10.  Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice.

Authors:  Joseph E Labrie; Alex P Sah; David M Allman; Michael P Cancro; Rachel M Gerstein
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.